eudesmane has been researched along with beta-escin in 1 studies
| Studies (eudesmane) | Trials (eudesmane) | Recent Studies (post-2010) (eudesmane) | Studies (beta-escin) | Trials (beta-escin) | Recent Studies (post-2010) (beta-escin) |
|---|---|---|---|---|---|
| 93 | 0 | 53 | 14,137 | 211 | 6,278 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atanasov, AG; Blaschke, M; Diaz, R; Dirsch, VM; Ecker, GF; Feistel, B; Frisch, R; Grusch, M; Holzner, S; Jäger, W; Kopp, B; Krieger, S; Krupitza, G; McKinnon, R; Nguyen, CH; Schelch, K; Urban, E; Zehl, M; Zupko, I | 1 |
1 other study(ies) available for eudesmane and beta-escin
| Article | Year |
|---|---|
A eudesmane-type sesquiterpene isolated from Pluchea odorata (L.) Cass. combats three hallmarks of cancer cells: Unrestricted proliferation, escape from apoptosis and early metastatic outgrowth in vitro.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Asteraceae; Cell Cycle; Cell Proliferation; HL-60 Cells; Humans; Inhibitory Concentration 50; Male; Plant Extracts; Rats; Rats, Sprague-Dawley; Saponins; Sesquiterpenes, Eudesmane; Spirostans | 2015 |